Predica Diagnostics just secured the Take Off 2 funding to accelerate development of their cervical (pre)cancer prediction test. Their targeted RNA-sequencing based diagnostic test will reduce the number of unnecessary follow-up diagnostic testing and unnecessary referrals to gynecologists. By identifying only those women who truly need further evaluation or treatment, Predica can provide peace of mind and minimize stress for healthy women who test false-positive during screening. And at the same time save on healthcare costs!
The 2023 spring round of Take-off allows 31 feasibility studies and 10 early-stage projects to get underway. Academic and innovative startups can use the feasibility studies to explore whether their innovative ideas have commercial or social applicability. If this proves feasible, they have the opportunity to start a business. The feasibility studies are for both academic applicants and startups from Applied Research Organizations (TO2). This time, 4 projects were also awarded again within the Commit2Data cluster.
Source (in Dutch): 41 nieuwe Take-off projecten toegekend | NWO
Related news items
Third Radboudumc Investment Day again well-attended16 October 2023
On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.read more
Boosting the startup ecosystem in Nijmegen!22 June 2023
TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.read more
Meet Healthy Ideas, Healthy Returns2 June 2023
Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.read more
Aftermovie Investment Day 2022 and a new date for 2023!13 December 2022
Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.read more
Enzyre closes Series A financing round of €12M to advance pioneering diagnostic technology platform for hemophilia patients2 November 2022
Enzyre has announced that it has successfully raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment, Takeda Ventures, and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government.read more
Successful matchmaking at Radboudumc Investment Day7 October 2022
On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.read more